He has a big audience and a huge voice with the administration – so what about Joe Rogan and marijuana?

In a surprising turn of events, hemp is starting to rival marijuana in sales, marking a significant shift in the cannabis industry landscape. As of 2025, the industrial hemp market has experienced explosive growth. Meanwhile, marijuana has acceptance by almost 90% of the country, but the 10% against it include leaders in DC. The small group seems to have blocked a path for profitably for thousands of mom and pop marijuana companies. Currently, it is unclear what the new administration will do with the rescheduling, SAFE Banking and more. But amid the chaos, hemp hums along ibeing carried in mainstream retailers like Total Wine and convience stores, allowing them access to large customer bases.

RELATED: Veterans With PTSD Are Given A Little Hope

“Hemp is living the cannabis dream. No 280E tax or punitive state excise taxes exist, while direct-to-consumer sales and interstate commerce are allowed. Intoxicating hemp is being treated like a regular commodity, while cannabis remains in the penalty box.” shared Jesse Redmond, an executive at LEEF Holdings.

Daniel Shortt, one of the partners at the Seattle firm Salzhauer & Shortt shares “At this stage, it is anyone’s guess how the new administration is going to approach cannabis. The new president has sent mixed message about cannabis, but it is clearly not a priority for the next few months which could be good for the largely unregulated hemp-derivative market.

The new administration began before the cannabis rescheduling process concluded, and an administrative law judge has now paused that process for at least 90 days. With the future of federal reform so uncertain, it’s likely that hemp products will continue to be sold widely across the country under the 2018 Farm Bill, despite significant pushback at the state level—unless Congress amends the next version of the Farm Bill. The current version of the Farm Bill governs the production of hemp but does not specifically regulate the manufacture and distribution of hemp products. While the FDA has opposed these products, it has done little to enforce actions against them. It seems unlikely that halting the spread of hemp products will be a priority for new adminstration’s FDA.”